Apollon develops noninvasive continuous glucose monitoring systems.
Apollon has raised $3.7M in total funding. The most recent round was Series A. The last funding was announced in September 2026.
Apollon's investors include SBI Investment, Naver, TheVentures, TIPS Program, STIC Ventures.
Apollon is headquartered in Cambridge, United States.
Apollon develops noninvasive continuous glucose monitoring systems.
Apollon is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Apollon — Funding & Investors." VCBacked, September 22, 2026, https://www.vcbacked.co/company/apollon. Accessed October 19, 2026.
VCBacked. (2026). Apollon — Funding & Investors. Retrieved October 19, 2026, from https://www.vcbacked.co/company/apollon
{{cite web |title=Apollon — Funding & Investors |url=https://www.vcbacked.co/company/apollon |website=VCBacked |access-date=October 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated